
Step 1
Demand new evidence before adding
Only add when business-level evidence improves expected value, not when price declines alone create emotional urgency.
Keyword: should i average down a losing stock
A clear framework for deciding whether averaging down improves expected value or only increases risk concentration.
Averaging down can be intelligent or destructive. The difference is whether your thesis strengthened with new evidence or you are defending sunk cost.

This page follows KeepRule landing standards for clarity, conversion paths, and shareability.

Step 1
Only add when business-level evidence improves expected value, not when price declines alone create emotional urgency.

Step 2
Averaging down increases concentration risk. Recheck total portfolio impact before any additional allocation.

Step 3
Set maximum number of adds and hard invalidation triggers in advance to avoid open-ended capital commitment.
Only add when business-level evidence improves expected value, not when price declines alone create emotional urgency.
Averaging down increases concentration risk. Recheck total portfolio impact before any additional allocation.
Set maximum number of adds and hard invalidation triggers in advance to avoid open-ended capital commitment.

It is bad when driven by ego or anchor bias; it can be valid when supported by stronger evidence and strict sizing discipline.
If thesis confidence is lower, balance-sheet risk is higher, or concentration limits are breached, do not add.
Keep it limited and predefined. Unlimited averaging is usually a sign of process failure.
Before your next add decision, write evidence criteria, size cap, and invalidation trigger in one checklist.